{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:54:35Z","timestamp":1791582875872,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Talent Program","award":["CQYC20200303142"],"award-info":[{"award-number":["CQYC20200303142"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-025-03196-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:38:18Z","timestamp":1751359098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of corticosteroids in critically ill patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Lei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"23","key":"3196_CR1","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u201373. https:\/\/doi.org\/10.1056\/NEJMra2026131.","journal-title":"N Engl J Med"},{"issue":"6","key":"3196_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377(6):562\u201372. https:\/\/doi.org\/10.1056\/NEJMra1608077.","journal-title":"N Engl J Med"},{"issue":"6","key":"3196_CR3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"PE Marik","year":"2008","unstructured":"Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American college of critical care medicine. Crit Care Med. 2008;36(6):1937\u201349. https:\/\/doi.org\/10.1097\/CCM.0b013e31817603ba.","journal-title":"Crit Care Med"},{"issue":"12","key":"3196_CR4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00134-017-4914-x","volume":"43","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Arlt W, et al. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the society of critical care medicine (SCCM) and the European society of intensive care medicine (ESICM). Intensive Care Med. 2017;43(12):1781\u201392. https:\/\/doi.org\/10.1007\/s00134-017-4914-x.","journal-title":"Intensive Care Med"},{"issue":"19","key":"3196_CR5","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.3390\/ijms20194765","volume":"20","author":"D Mokra","year":"2019","unstructured":"Mokra D, Mikolka P, Kosutova P, Mokry J. Corticosteroids in acute lung injury: the dilemma continues. Int J Mol Sci. 2019;20(19):4765. https:\/\/doi.org\/10.3390\/ijms20194765. Published 2019 Sep 25.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"3196_CR6","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711\u201323. https:\/\/doi.org\/10.1056\/NEJMra050541.","journal-title":"N Engl J Med"},{"issue":"11","key":"3196_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00134-011-2334-x","volume":"37","author":"R Moreno","year":"2011","unstructured":"Moreno R, Sprung CL, Annane D, et al. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the corticus study. Intensive Care Med. 2011;37(11):1765\u201372. https:\/\/doi.org\/10.1007\/s00134-011-2334-x.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3196_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.ccm.0000194723.78632.62","volume":"34","author":"D Annane","year":"2006","unstructured":"Annane D, S\u00e9bille V, Bellissant E, Ger-Inf-05 Study Group. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006;34(1):22\u201330. https:\/\/doi.org\/10.1097\/01.ccm.0000194723.78632.62.","journal-title":"Crit Care Med"},{"issue":"21","key":"3196_CR9","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, et al. Hydrocortisone in severe Community-Acquired pneumonia. N Engl J Med. 2023;388(21):1931\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2215145.","journal-title":"N Engl J Med"},{"issue":"3","key":"3196_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376. https:\/\/doi.org\/10.1016\/S2213-2600(19)30417-5.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"3196_CR11","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Executive summary: surviving Sepsis campaign: international guidelines for the management of Sepsis and septic shock 2021. Crit Care Med. 2021;49(11):1974\u201382. https:\/\/doi.org\/10.1097\/CCM.0000000000005357.","journal-title":"Crit Care Med"},{"issue":"7","key":"3196_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/thoraxjnl-2015-206881","volume":"70","author":"WS Lim","year":"2015","unstructured":"Lim WS, Smith DL, Wise MP, Welham SA, British Thoracic Society. British thoracic society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together. Thorax. 2015;70(7):698\u2013700. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-206881.","journal-title":"Thorax"},{"issue":"7","key":"3196_CR13","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with Community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3196_CR14","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","volume":"158","author":"MW Pletz","year":"2020","unstructured":"Pletz MW, Blasi F, Chalmers JD, et al. International perspective on the new 2019 American thoracic society\/infectious diseases society of America Community-Acquired pneumonia guideline: A critical appraisal by a global expert panel. Chest. 2020;158(5):1912\u20138. https:\/\/doi.org\/10.1016\/j.chest.2020.07.089.","journal-title":"Chest"},{"issue":"9","key":"3196_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1705716.","journal-title":"N Engl J Med"},{"issue":"9","key":"3196_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835.","journal-title":"N Engl J Med"},{"issue":"8","key":"3196_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L, et al. Low-dose Methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48(8):1009\u201323. https:\/\/doi.org\/10.1007\/s00134-022-06684-3.","journal-title":"Intensive Care Med"},{"key":"3196_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"3196_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"7650","key":"3196_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"key":"3196_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","volume":"15","author":"C R\u00f6ver","year":"2015","unstructured":"R\u00f6ver C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol. 2015;15:99. https:\/\/doi.org\/10.1186\/s12874-015-0091-1.","journal-title":"BMC Med Res Methodol"},{"key":"3196_CR22","unstructured":"Deeks JJ, Higgins JPT, Altman DG,Chapter 10: Analysing data and undertaking meta-analyses. In:, Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"3196_CR23","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res"},{"key":"3196_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"issue":"32","key":"3196_CR25","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","volume":"192","author":"S Schandelmaier","year":"2020","unstructured":"Schandelmaier S, Briel M, Varadhan R, et al. Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses. CMAJ. 2020;192(32):E901\u20136. https:\/\/doi.org\/10.1503\/cmaj.200077.","journal-title":"CMAJ"},{"issue":"2","key":"3196_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jama.280.2.159","volume":"280","author":"GU Meduri","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E, et al. Effect of prolonged Methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159\u201365. https:\/\/doi.org\/10.1001\/jama.280.2.159.","journal-title":"JAMA"},{"issue":"4","key":"3196_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1378\/chest.06-2100","volume":"131","author":"GU Meduri","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954\u201363. https:\/\/doi.org\/10.1378\/chest.06-2100.","journal-title":"Chest"},{"key":"3196_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejcdt.2013.02.013","volume":"62","author":"N Abdelsalam Rezk","year":"2013","unstructured":"Abdelsalam Rezk N, Mohamed Ibrahim A. Effects of Methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberc. 2013;62:167\u201372. https:\/\/doi.org\/10.1016\/j.ejcdt.2013.02.013.","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"16","key":"3196_CR29","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671\u201384. https:\/\/doi.org\/10.1056\/NEJMoa051693.","journal-title":"N Engl J Med"},{"issue":"1","key":"3196_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo S, Permpikul C, Mongkolpun W, et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20(1):329. https:\/\/doi.org\/10.1186\/s13054-016-1511-2.","journal-title":"Crit Care"},{"issue":"25","key":"3196_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","volume":"317","author":"GR Bernard","year":"1987","unstructured":"Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317(25):1565\u201370. https:\/\/doi.org\/10.1056\/NEJM198712173172504.","journal-title":"N Engl J Med"},{"issue":"3","key":"3196_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242\u20138. https:\/\/doi.org\/10.1164\/rccm.200406-808OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3196_CR33","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc10103","volume":"15","author":"S Fern\u00e1ndez-Serrano","year":"2011","unstructured":"Fern\u00e1ndez-Serrano S, Dorca J, Garcia-Vidal C, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care. 2011;15(2):R96. https:\/\/doi.org\/10.1186\/cc10103.","journal-title":"Crit Care"},{"issue":"2","key":"3196_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1378\/chest.104.2.389","volume":"104","author":"P Marik","year":"1993","unstructured":"Marik P, Kraus P, Sribante J, Havlik I, Lipman J, Johnson DW. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest. 1993;104(2):389\u201392. https:\/\/doi.org\/10.1378\/chest.104.2.389.","journal-title":"Chest"},{"key":"3196_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","volume":"62","author":"RM Nafae","year":"2013","unstructured":"Nafae RM, Ragab MI, Amany FM, et al. Adjuvant role of corticosteroids in the treatment of community-acquired pneu-monia. Egypt J Chest Dis Tuberc. 2013;62:439\u201345. https:\/\/doi.org\/10.1016\/j.ejcdt.2013.03.009.","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"3196_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4236\/pp.2011.22009","volume":"02","author":"NA Sabry","year":"2011","unstructured":"Sabry NA, Omar EE-D. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm. 2011;02:73\u201381. https:\/\/doi.org\/10.4236\/pp.2011.22009.","journal-title":"Pharmacol Pharm"},{"issue":"7","key":"3196_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677\u201386. https:\/\/doi.org\/10.1001\/jama.2015.88.","journal-title":"JAMA"},{"key":"3196_CR38","first-page":"91","volume":"55","author":"A El-Ghamrawy","year":"2006","unstructured":"El-Ghamrawy A, Shokeir M, Esmat A. Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia. Egypt J Chest. 2006;55:91\u20139.","journal-title":"Egypt J Chest"},{"issue":"11","key":"3196_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose Methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317(11):653\u20138. https:\/\/doi.org\/10.1056\/NEJM198709103171101.","journal-title":"N Engl J Med"},{"issue":"11","key":"3196_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM198709103171102","volume":"317","author":"Veterans Administration Systemic Sepsis Cooperative Study Group","year":"1987","unstructured":"Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317(11):659\u201365. https:\/\/doi.org\/10.1056\/NEJM198709103171102.","journal-title":"N Engl J Med"},{"issue":"17","key":"3196_CR41","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2016.14799","volume":"316","author":"D Keh","year":"2016","unstructured":"Keh D, Trips E, Marx G, et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA. 2016;316(17):1775\u201385. https:\/\/doi.org\/10.1001\/jama.2016.14799.","journal-title":"JAMA"},{"issue":"3","key":"3196_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/cc1498","volume":"6","author":"O Yildiz","year":"2002","unstructured":"Yildiz O, Doganay M, Aygen B, G\u00fcven M, Kele\u015ftimur F, Tutu\u00fb A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care. 2002;6(3):251\u20139. https:\/\/doi.org\/10.1186\/cc1498.","journal-title":"Crit Care"},{"issue":"11","key":"3196_CR43","first-page":"1410","volume":"16","author":"O Yildiz","year":"2011","unstructured":"Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kelestimur F. The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study. J Res Med Sci. 2011;16(11):1410\u201321.","journal-title":"J Res Med Sci"},{"issue":"18","key":"3196_CR44","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1503\/cmaj.090707","volume":"182","author":"YM Arabi","year":"2010","unstructured":"Arabi YM, Aljumah A, Dabbagh O, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182(18):1971\u20137. https:\/\/doi.org\/10.1503\/cmaj.090707.","journal-title":"CMAJ"},{"issue":"6","key":"3196_CR45","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","volume":"42","author":"AC Gordon","year":"2014","unstructured":"Gordon AC, Mason AJ, Perkins GD, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42(6):1325\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000000212.","journal-title":"Crit Care Med"},{"issue":"5","key":"3196_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/08850666211038883","volume":"37","author":"D Birudaraju","year":"2022","unstructured":"Birudaraju D, Hamal S, Tayek JA. Solumedrol treatment for severe Sepsis in humans with a blunted adrenocorticotropic Hormone-Cortisol response: A prospective randomized Double-Blind Placebo-Controlled pilot clinical trial. J Intensive Care Med. 2022;37(5):693\u20137. https:\/\/doi.org\/10.1177\/08850666211038883.","journal-title":"J Intensive Care Med"},{"issue":"4","key":"3196_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","volume":"26","author":"PE Bollaert","year":"1998","unstructured":"Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with Supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26(4):645\u201350. https:\/\/doi.org\/10.1097\/00003246-199804000-00010.","journal-title":"Crit Care Med"},{"issue":"4","key":"3196_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","volume":"27","author":"J Briegel","year":"1999","unstructured":"Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27(4):723\u201332. https:\/\/doi.org\/10.1097\/00003246-199904000-00025.","journal-title":"Crit Care Med"},{"issue":"1S","key":"3196_CR49","doi-asserted-by":"publisher","first-page":"33A","DOI":"10.1097\/00003246-199901001-00022","volume":"27","author":"K Chawla","year":"1999","unstructured":"Chawla K, Kupfer Y, Goldman I, et al. Hydrocortisone reverses refractory septic shock. Crit Care Med. 1999;27(1S):33A. https:\/\/doi.org\/10.1097\/00003246-199901001-00022.","journal-title":"Crit Care Med"},{"issue":"4","key":"3196_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1590\/s1516-31802007000400009","volume":"125","author":"DD Cicarelli","year":"2007","unstructured":"Cicarelli DD, Vieira JE, Bense\u00f1or FE. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J. 2007;125(4):237\u201341. https:\/\/doi.org\/10.1590\/s1516-31802007000400009.","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"3196_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","volume":"138","author":"JM Luce","year":"1988","unstructured":"Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose Methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138(1):62\u20138. https:\/\/doi.org\/10.1164\/ajrccm\/138.1.62.","journal-title":"Am Rev Respir Dis"},{"issue":"12","key":"3196_CR52","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","volume":"35","author":"QQ Lv","year":"2017","unstructured":"Lv QQ, Gu XH, Chen QH, Yu JQ, Zheng RQ. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial. Am J Emerg Med. 2017;35(12):1810\u20134. https:\/\/doi.org\/10.1016\/j.ajem.2017.06.004.","journal-title":"Am J Emerg Med"},{"key":"3196_CR53","doi-asserted-by":"publisher","unstructured":"Meduri GU, Golden E, Umberger R. Prospective double-blind randomized clinical trial on the effects of low-dose hydrocor-tisone infusion in patients with severe sepsis. Chest. 2009; 136:Supplement 45S. https:\/\/doi.org\/10.1016\/s0012-3692(16)48001-3","DOI":"10.1016\/s0012-3692(16)48001-3"},{"issue":"11","key":"3196_CR54","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/01.ccm.0000186370.78639.23","volume":"33","author":"M Oppert","year":"2005","unstructured":"Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33(11):2457\u201364. https:\/\/doi.org\/10.1097\/01.ccm.0000186370.78639.23.","journal-title":"Crit Care Med"},{"issue":"9","key":"3196_CR55","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/01.CCM.0000233872.04706.BB","volume":"34","author":"S Rinaldi","year":"2006","unstructured":"Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med. 2006;34(9):2334\u20139. https:\/\/doi.org\/10.1097\/01.CCM.0000233872.04706.BB.","journal-title":"Crit Care Med"},{"issue":"3","key":"3196_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","volume":"184","author":"W Schumer","year":"1976","unstructured":"Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976;184(3):333\u201341. https:\/\/doi.org\/10.1097\/00000658-197609000-00011.","journal-title":"Ann Surg"},{"issue":"18","key":"3196_CR57","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","volume":"311","author":"CL Sprung","year":"1984","unstructured":"Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984;311(18):1137\u201343. https:\/\/doi.org\/10.1056\/NEJM198411013111801.","journal-title":"N Engl J Med"},{"issue":"2","key":"3196_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111\u201324. https:\/\/doi.org\/10.1056\/NEJMoa071366.","journal-title":"N Engl J Med"},{"key":"3196_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15171\/JEPT.2017.25","volume":"4","author":"M Talebi Doluee","year":"2018","unstructured":"Talebi Doluee M, Salehi M, Mahmoudi Gharaee A, et al. The effect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: A randomized control trial. J Emerg Pract Trauma. 2018;4:29\u201333. https:\/\/doi.org\/10.15171\/JEPT.2017.25.","journal-title":"J Emerg Pract Trauma"},{"issue":"7","key":"3196_CR60","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D, S\u00e9bille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862\u201371. https:\/\/doi.org\/10.1001\/jama.288.7.862.","journal-title":"JAMA"},{"issue":"2","key":"3196_CR61","first-page":"11","volume":"70","author":"M Agarwal","year":"2022","unstructured":"Agarwal M, Dhar M, Agarwal D, Murlidharan A. Early initiation of Low-Dose hydrocortisone therapy for septic shock in geriatric patients: A randomized control trial. J Assoc Physicians India. 2022;70(2):11\u20132.","journal-title":"J Assoc Physicians India"},{"key":"3196_CR62","unstructured":"Tandan S, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India. Proceedings of the 2005 American Thoracic Society Meeting. New York; 2005."},{"issue":"2","key":"3196_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","volume":"179","author":"F Fang","year":"2019","unstructured":"Fang F, Zhang Y, Tang J, et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis: A systematic review and Meta-analysis. JAMA Intern Med. 2019;179(2):213\u201323. https:\/\/doi.org\/10.1001\/jamainternmed.2018.5849.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"3196_CR64","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","volume":"46","author":"B Rochwerg","year":"2018","unstructured":"Rochwerg B, Oczkowski SJ, Siemieniuk RAC, et al. Corticosteroids in sepsis: an updated systematic review and Meta-Analysis. Crit Care Med. 2018;46(9):1411\u201320. https:\/\/doi.org\/10.1097\/CCM.0000000000003262.","journal-title":"Crit Care Med"},{"issue":"7","key":"3196_CR65","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","volume":"44","author":"SL Ryg\u00e5rd","year":"2018","unstructured":"Ryg\u00e5rd SL, Butler E, Granholm A, et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44(7):1003\u201316. https:\/\/doi.org\/10.1007\/s00134-018-5197-6.","journal-title":"Intensive Care Med"},{"issue":"10","key":"3196_CR66","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","volume":"209","author":"B Teja","year":"2024","unstructured":"Teja B, Berube M, Pereira TV, et al. Effectiveness of fludrocortisone plus hydrocortisone versus hydrocortisone alone in septic shock: A systematic review and network Meta-Analysis of randomized controlled trials. Am J Respir Crit Care Med. 2024;209(10):1219\u201328. https:\/\/doi.org\/10.1164\/rccm.202310-1785OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3196_CR67","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13054-023-04561-z","volume":"27","author":"JY Wu","year":"2023","unstructured":"Wu JY, Tsai YW, Hsu WH, et al. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):274. https:\/\/doi.org\/10.1186\/s13054-023-04561-z.","journal-title":"Crit Care"},{"issue":"3","key":"3196_CR68","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.chest.2022.08.2229","volume":"163","author":"N Saleem","year":"2023","unstructured":"Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N. Effect of corticosteroids on mortality and clinical cure in Community-Acquired pneumonia: A systematic review, Meta-analysis, and Meta-regression of randomized control trials. Chest. 2023;163(3):484\u201397. https:\/\/doi.org\/10.1016\/j.chest.2022.08.2229.","journal-title":"Chest"},{"issue":"5","key":"3196_CR69","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","volume":"47","author":"D Chaudhuri","year":"2021","unstructured":"Chaudhuri D, Sasaki K, Karkar A, et al. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med. 2021;47(5):521\u201337. https:\/\/doi.org\/10.1007\/s00134-021-06394-2.","journal-title":"Intensive Care Med"},{"issue":"2","key":"3196_CR70","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","volume":"210","author":"AC Gordon","year":"2024","unstructured":"Gordon AC, Alipanah-Lechner N, Bos LD, et al. From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU. Am J Respir Crit Care Med. 2024;210(2):155\u201366. https:\/\/doi.org\/10.1164\/rccm.202311-2086SO.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3196_CR71","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/14737159.2023.2258063","volume":"23","author":"E Kyriazopoulou","year":"2023","unstructured":"Kyriazopoulou E, Giamarellos-Bourboulis EJ, Akinosoglou K. Biomarkers to guide Immunomodulatory treatment: where do we stand? Expert Rev Mol Diagn. 2023;23(11):945\u201358. https:\/\/doi.org\/10.1080\/14737159.2023.2258063.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"3196_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14737159.2020.1851199","volume":"21","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Giamarellos-Bourboulis EJ. Monitoring Immunomodulation in patients with sepsis. Expert Rev Mol Diagn. 2021;21(1):17\u201329. https:\/\/doi.org\/10.1080\/14737159.2020.1851199.","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"3196_CR73","doi-asserted-by":"publisher","first-page":"e066496","DOI":"10.1136\/bmjopen-2022-066496","volume":"13","author":"J Fleuriet","year":"2023","unstructured":"Fleuriet J, Heming N, Meziani F, et al. Rapid rEcognition of corticosteroid resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive bayesian design basket trial. BMJ Open. 2023;13(3):e066496. https:\/\/doi.org\/10.1136\/bmjopen-2022-066496. Published 2023 Mar 10.","journal-title":"BMJ Open"},{"issue":"6","key":"3196_CR74","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023;49(6):615\u201332. https:\/\/doi.org\/10.1007\/s00134-023-07033-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3196_CR75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L, et al. An update on management of adult patients with acute respiratory distress syndrome: an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2024;209(1):24\u201336. https:\/\/doi.org\/10.1164\/rccm.202311-2011ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3196_CR76","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00134-024-07431-6","volume":"50","author":"SK Sahetya","year":"2024","unstructured":"Sahetya SK, Rochwerg B, Fan E. Mind the gap: Understanding the discordance between the ATS and ESICM ARDS guidelines-the ATS perspective. Intensive Care Med. 2024;50(6):937\u201340. https:\/\/doi.org\/10.1007\/s00134-024-07431-6.","journal-title":"Intensive Care Med"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03196-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03196-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03196-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:38:19Z","timestamp":1751359099000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-025-03196-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3196"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03196-7","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}